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Innate and adaptive immunity play a significant role in trichomoniasis, the most common
non-viral sexually transmitted disease worldwide. In the urogenital tract, innate immunity
is accomplished by a defense physical barrier constituted by epithelial cells, mucus, and
acidic pH. During infection, immune cells, antimicrobial peptides, cytokines, chemokines,
and adaptive immunity evolve in the reproductive tract, and a proinflammatory response
is generated to eliminate the invading extracellular pathogen Trichomonas vaginalis. How-
ever, the parasite has developed complex evolutionary mechanisms to evade the host
immune response through cysteine proteases, phenotypic variation, and molecular mim-
icry. The purinergic system constitutes a signaling cellular net where nucleotides and
nucleosides, enzymes, purinoceptors and transporters are involved in almost all cells and
tissues signaling pathways, especially in central and autonomic nervous systems, endo-
crine, respiratory, cardiac, reproductive, and immune systems, during physiological as well
as pathological processes. The involvement of the purinergic system in T. vaginalis biology
and infection has been demonstrated and this review highlights the participation of this
signaling pathway in the parasite immune evasion strategies.Human trichomoniasis is the most common non-viral sexu-
ally transmitted infection caused by the parasite Trichomonas
vaginaliswith an incidence of 276 million new cases each year
[1]. The vaginal squamous epithelium is the primary site of
infection, although the parasite may also reach urethra and
endocervix [2,3]. In men, the parasite leads to urethra infec-
tion and the presence of trophozoites in the prostate gland has
been demonstrated [2,4]. Updated data revealed thath Laboratory, Pharmacy
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/by-nc-nd/4.0/).approximately 80% of T. vaginalis infections are asymptomatic
in both men and women [5e7].
In symptomatic women, the clinical manifestations are
vaginal discharge, pruritus, odor, and irritation [3]. The typical
vaginal discharge is caused due to intense leukocytic infiltra-
tion within the genital tract mainly promoted as consequence
of epithelial cell death mediated by inflammation and
recruitment of polymorphonuclear leukocytes [8]. In contrastFaculty, Federal University of Rio Grande do Sul, Ipiranga Avenue,
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which seems to be associated to the characteristics of male
genital fluid enriched in zinc that displays a critical cytotoxic
effect [9]. If present, men urethritis is associated with
discharge, dysuria, and mild pruritus or burning sensation
immediately after sexual intercourse [10].
Studies support that the impact of trichomoniasis is not
restrict to vaginal or urethral site infection but also presents a
major influence in HIV transmission and acquisition [11,12], in
the risk of cervical [13] and prostate cancer [14e16] and is also
related to adverse pregnancy outcomes [17,18] and female and
male infertility [9,19]. Despite all serious consequences
attributed to the T. vaginalis infection the treatment is still
restrict to a single therapeutic option, the nitroimidazole drug
family, mainly represented by metronidazole and tinidazole.
Besides the problematic associated to side effects, lack of
treatment of sexual partners, inaccurate diagnosis, the
increasing number of drug resistance in clinical isolates is
relevant [10,20,21]. It has become clear that the impact of
trichomoniasis on public health demands early and correct
diagnosis, prompt treatment and constant studies on patho-
genicmechanisms and host immune response involved in the
infection.
The purinergic system constitutes a signaling cellular net
that employs purines and pyrimidines as effectors com-
pounds, which may be inactivated by enzymes named
ectonucleotidases or uptake by cells through transporters or
they can bind to purinoceptors [22]. The purinergic system is
involved in almost all cells and tissues signaling pathways,
especially in central and autonomic nervous systems,
endocrine, respiratory, cardiac, reproductive and immune
systems, during physiological as well as pathological pro-
cesses [23].
In this context, the aim of this review was to highlight the
immunological aspects involved in T. vaginalis infection, with
focus on the purinergic signaling involvement in the parasite
immune response evasion mechanisms.Innate immunity
The female reproductive tract is a particular immunological
site that plays a pivotal role on mucosa protection from a
variety of pathogens. Besides this crucial function, the
mucosal immune system of the female genital tract is in
constant adaptation in order to respond to the many physio-
logical processes that take place at this site. Hormone mod-
ulation, conception, pregnancy and protection against
pathogens are some events that constantly modulate innate
and adaptive responses at mucosal level [24]. In comparison
with female tract, less information is available regarding the
immune system in male urogenital tract, especially due to
limitation on sample availability, as impermeable stratified
squamous epithelium of the penile urethra difficult the
collection [25]. In this sense, it is increasing the number of
immunological studies in epithelial cell lines or alternative
samples aiming to characterize innate and adaptive immune
responses in male reproductive tract.
A distinguishing aspect of the male and female genital
tract is the both immune responses activated at these sites:systemic immunity and mucosal immune reaction [24]. The
immune responses in the reproductive tract are mediated
by interactions between cells, anatomic components and
molecules that constitutes the complex microenvironment
regulated by sex hormones and specific microbiome [26,27].
Regardless of the site, the development of a multiplicity of
immunological mechanisms allowed the host to prevent
establishment or dissemination of pathogenic infections.
Barrier protection: epithelial cells, mucus, pH
The epithelial cells and mucus present in the female
reproductive tract provide a strong physical barrier that
prevent the transmission of microorganisms and specially,
sexually transmitted infections [28]. The luminal portion of
female reproductive tract is composed of columnar epithe-
lial cells closely connected with tight junctions whose
integrity is maintained by many factors as hormones and
chemokines [26,29]. In the male reproductive tract, the
urethral mucosa and the testes are responsible for immune
responses in consequence of cytokines autocrine and
paracrine release [30].
Integrating the physical barrier that prevents the patho-
gen's entry into the female and male reproductive tract, the
mucus layer comprises a dense gel phase capable of trapping
invasive microorganisms. Mucin family consists of glycosy-
lated proteins that are present and expressed specifically at
the apical surface of epithelial cells through genital tract
[31,32]. Beyond those features, cervico-vaginal mucus may
prevent the transmission of many pathogens because of the
low pH, maintained by lactic acid produced by commensal
bacteria, mainly Lactobacillus spp., in normal reproductive
cycle of healthy women [33]. It was demonstrated that an in-
crease in the vaginal pH and anaerobic bacteria are used for
the clinical diagnosis of infections including bacterial vagi-
nosis caused byGardnerella vaginalis (pH > 4.5) and the parasite
T. vaginalis (pH 5.0e6.0) [34]. The cellular and physiological
constitution of female reproductive tract, including these
complex components dynamically controls the initial process
of establishing pathogen infection.
T. vaginalis infection: overcoming the barriers from
epithelial cells and strategies of immune response evasion
As an extracellular pathogen, T. vaginalis infects the epithelial
layer of human reproductive tract and for the success of the
colonization and survival of the trophozoites the parasite
must adhere to epithelial cells. The host environment is
constantly changing because of diverse biological processes
and the parasite needs to evade a series of non-specific host
defenses, including mucus, the structure of epithelial layer,
pH at the genital site, presence of chemokines and another
soluble factors.
T. vaginalis is able to traverse the mucus layer first by
mucin binding followed by its proteolytic degradation [35]. It
was demonstrated that the parasite binds to mucin possibly
by a lectin-like adhesion and proteinase action is activated
[35]. The continued release of these proteinsmay contribute to
desquamation of epithelial cells, leading to the destruction of
monolayers and allowing the penetrance of the parasite [36].
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teases (CPs) are involved in immune evading mechanisms. It
has been shown that CPs can degrade all subclasses of host
immunoglobulins produced in response to the infection, as
well as extracellular matrix proteins and hemoglobin [37e40].
Another interesting advantage for parasitism is the defi-
cient complement system observed in cervical mucus and
vagina, as themajority of complement available ismaintained
by red blood cells only during menstruation [41,42]. Alterna-
tive complement activation is a nonspecific defense mecha-
nism against microorganisms, and it has been demonstrated
that T. vaginalis activates this pathway. At the same time, the
parasite avoids the complement lysis as a strategic mecha-
nism to evade immune responses [43]. Iron, an essential
nutritional and metabolic element for T. vaginalis parasitism
presents high levels during menses and seems to be involved
in the resistance to complement lysis. High iron concentra-
tions are involved in the upregulation of parasite CPs leading
to degradation of complement C3 portion. This particular
modulation by iron contributes to the evasion of the immune
response [41].
Recognition of pathogens and antimicrobial peptides
Besides the physical protection, the female and male genital
immune system evolved the ability to discriminate their own
cells and molecular compounds and in consequence the
recognition of pathogens. In this context, innate immune
recognition is mediated through the expression of the
pattern recognition receptors (PRRs), mainly presented by
Toll-like (TLRs) and NOD-like (NLRs) receptors. These re-
ceptors are involved in prevention and control of invasive
pathogens, through recognition of unfamiliar structures to
the host [44]. Once stimulated, PRRs mediate direct killing of
pathogens, secretion of cytokines, chemokines and antimi-
crobial peptides and signal for activation of adaptive re-
sponses [45,46]. Human female reproductive tract expresses
TLRs in vaginal, endocervical, and epithelial cells [47e49]. It
was demonstrated that a variety of immune signals are
stimulated by the TLRs in the female tract such as release of
cytokines IL-6 and IL-8 [48] in endocervical epithelial cells,
recognition of invading pathogens [50], immunity in female
reproductive tract, and the modulation of intracellular
signaling of nuclear factor-kB (NF-kB) [50]. The role of pattern
recognition receptors along the male genital tract was
recently evidenced [51]. TLR expression is relatively rare in
the deeper tissues of the male genital tract except in the
penile urethra where a large number of cells express diverse
TLRs. These tissues express TLR9, a receptor that detects
viral nucleic acids and plays an important role in antiviral
immune defense [52].
Antimicrobial peptides (AMPs) are widely expressed by
numerous cell types in mucosal epithelia including DCs,
macrophages, neutrophils, NK and epithelial cells, and their
cell surface expression can be upregulated during initial
stages of infection [53]. AMPs have been studied in mucosal
secretions and they include small antimicrobial proteins
(defensins and cathelicidins) and large proteins (lysozyme,
azurocidin, cathepsin G, phospholipase A2, serine leukocyte
protease inhibitor, and lactoferrin). Human alpha and beta-defensins are the most abundant AMPs described for the fe-
male reproductive tract and are particularly regulated in the
upper and lower portions of the tract depending on the
menstrual cycle [24]. It was already demonstrated that
defensins have anti-microbial properties against different
pathogens, including the HIV virus [24]. In male reproductive
tract it was already demonstrated the expression of defensins
in urethral secretions during Chlamydia trachomatis and Neis-
seria gonorrhea urethritis in men [54].
Escaping from pathogen recognition and the regulation of
antimicrobial peptides secretion during trichomoniasis
Molecular mimicry is defined as structural, functional or
immunological similarities shared between macromolecules
found on pathogens and host tissues. The parasite T. vaginalis
can also coat itself with host plasma proteins to avoid being
recognized as strange by the host immune system [2]. This
parasite adaptation prevents the recognition of the pathogen-
associated molecular patterns (PAMPs) and consequently the
immune response triggering such as antigen presentation and
complement-mediated lysis will not occur.
Like many other protozoan parasites, T. vaginalis displays
phenotypic variation as a mechanism of immune evasion. It
was already shown the involvement of two surface immu-
nogens (P230 and P270) in the parasite phenotypic variation.
The phenotypic variation for P230 is present on the surface of
parasites but undergoes conformational changes that
prevent the accessibility of the epitope to antibody binding,
allowing it to evade antibody response [55]. On the other hand,
the surface expression of P270 is based on the presence of
dsRNA virus in the trophozoite cytoplasm and iron concen-
tration [56].
Secretory leukocyte protease inhibitor (SLPI) is a kind of
antimicrobial peptide and plays an important role inmale and
female mucosal protection. T. vaginalis cysteine proteases are
able to degrade SLPI and turning it non-functional [57]. It was
already demonstrated that SLPI levels in the female genital
tract are reduced in a T. vaginalis-dependent manner [58]. SLPI
participates in the prevention of HIV transmission through
the inhibition of virus entry into monocytic cells in vitro [59].
These data together partially explain the observed increase in
risk of HIV acquisition in women with trichomoniasis [11,12].
Zinc is a known antimicrobial defense of the male lower
urinary tract against infections. The oxidative nature of the
male genital tract combined with high zinc concentration
(2.3e15.3 mM) in human prostatic secretions may be an
important defense against T. vaginalis infection. It is hypoth-
esized that zinc is inhibitory to certain pathogenic factors in
the parasite and is also toxic to the trophozoite [60]. An
interesting investigation demonstrated that there are varia-
tions in zinc sensitivity between different infecting T. vaginalis
isolates or in the zinc content of host prostatic secretions [60]
which may impact symptomatology, spontaneous cure rates,
and chronification of the infection in men [60]. More recently,
a proteome study revealed that variations in the zinc con-
centrations are able to induce differential expression of the T.
vaginalis proteome corroborating that this environmental
molecule plays a pivotal role in parasite survival in the
adverse environment of male urinary tract [61].
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lished that superoxide radicals, nitric oxide (NO) and other
reactive nitrogen species released by immune effector cells
are essential cytotoxic mediators against a diversity of mi-
croorganisms including parasites. It was already demon-
strated that NO products released by macrophages are
cytotoxic to T. vaginalis suggesting an important role to these
immune cells in the host defense mechanism against the
parasite [62]. In addition, the stimulation ofmacrophages with
live T. vaginalis induces an increase on NO production and
expression of inducible NO synthase (iNOS) levels [63]. Reac-
tive nitrogen radicals may also have a role in limiting T. vag-
inalis infection, as the levels of these mediators and iNOS
protein are different in leukocytes and vaginal washes of
healthy, symptomatic or asymptomatic women [64]. Neutro-
phils are the major cells recruited to the infection site, medi-
ating the initial inflammatory response after an acute T.
vaginalis infection [65] and also mediate the release of NO
under parasite stimulation condition [66]. Regarding reactive
oxygen intermediates, it was already demonstrated that their
production is detected after neutrophils and trichomonads co-
incubation as the participation of these molecules in these
immune cells apoptosis cascade [67].
Innate immune cells in female and male reproductive tract e
presence, function and immune response modulation
Neutrophils are present throughout the female reproductive
tract with highest numbers in the uterine tubes and gradually
decrease from the upper female reproductive tract into the
vagina [24]. Neutrophils express TLRs 1e9 and respond to
pathogens through phagocytosis, production of oxidative
compounds, release of antimicrobial peptides (defensins,
phospholipases) and cytokines. They represent an important
innate immune defense once the epithelial barrier is dis-
rupted. Epithelial cells of both the upper and lower repro-
ductive tracts produce abundant amounts of IL-8, which is a
leukocyte chemoattractant factor [68]. The number of neu-
trophils varies in the endometrium portion during menstrual
cycle but remains stable in the vagina, regardless of the period
[68].
Important phagocytic cells in innate immune cells are
macrophages and DCs, which represent around 10% of the
leukocytes present in the female reproductive tract [68].
Macrophages and DCs are competent antigen presenting cells
(APCs) crucial for the induction of adaptive immune responses
during infection [69]. Natural killer cells possess cytotoxic
activity and constitute about 70% ofmucosal leukocytes in the
endometrium [68]. Similar to blood NK cells, uterine NK cells
produce pro-inflammatory cytokines such as granulocyte-
macrophage colony-stimulating factor (GM-CSF), IL-10, IL-8
and IFNg and thus stimulate the inflammatory response,
inducing macrophage activation and cytotoxic T cell genera-
tion [28,68,70].
In relation to male reproductive tract, many types of im-
mune cells are present in the urethra and testes, with a
prevalence of macrophages, neutrophils, NK and mast cells
[25]. In relation to immune functions, mast cells upregulate
monocyte chemoattractant protein-1 and thereby recruit
macrophages into the testes [25]. Both CD8 and CD4 T cellsare present in the epithelium and lamina propria of the
urethra with a more abundant presence of CD8 T cell. Based
on these studies, it is clear that the lower male reproductive
tract is an immunologically competent site that is capable of
generating both cellular and humoral immunological re-
sponses. However, further studies into their functions in
immune responses in the male reproductive site need to be
carried out since their role in many immune processes re-
mains unclear.
Cytokines and chemokines are chemical messengers that
maintain the normal homeostatic environment and regulate
many innate and immune functions in the female and male
reproductive tract [28]. The secretion of these molecules pro-
duces a hostile environment to pathogen survival either by
the prompt communication between the different immune
cell types or by the direct antimicrobial nature of these com-
pounds. Several studies have demonstrated the constitutive
secretion of numerous cytokines, including GM-CSF, gran-
ulocyte colony-stimulating factor (G-CSF), TNF-a, IL-1, IL-6,
leukemia inhibitory factor (LIF), TGF-b, and of chemokines
such as MIP-1b, monocyte chemoattractant protein-1 (MCP-1),
and IL-8 by epithelial cells from the cervix, uterus, and fallo-
pian tubes [48,71].
In the male reproductive tract, the cytokines and other
immune regulatory factors are mainly produced in the testes
by somatic cells, involved in the regulation of spermatogen-
esis and other testicular cell functions [25]. Cytokines and
other immune regulatory factors are released by various im-
mune cells present in the male genital tract, including mac-
rophages, monocytes, lymphocytes, DCs, and in response to
invasive antigen and pathogens. Chronic inflammation and
infection conditions also display an impact on the release of
these chemical molecules. In both female and male repro-
ductive tracts, cytokine expression and release are regulated
by multiple factors, including steroid hormones, the redox
system, and prostaglandins [71].
T. vaginalis infection: suppressing cell immunity and the
effects of immune mediators during infection
The immunomodulatory responses to T. vaginalis infection
have been studied in vitro with cervical and vaginal epithelial
cell lines in association with various immune cell types. As a
mucosal pathogen, T. vaginalis must adhere to epithelial cell
monolayer and once in contact with host cells, the parasite
undergoes a drastic morphological shift that leads to tight
association to the target cells [72]. The TLRs expression plays a
significant role in the innate and adaptive immune responses
in epithelial cells, particularly TLR4 [73]. T. vaginalis infection
stimulates cells through TLR4 pathway, indicating a possible
immune mechanism mediated in the epithelial cells during
the parasite infection [73].
The outer layer membrane of T. vaginalis is covered by an
abundant glycoconjugate, the lipophosphoglycan (TvLPG).
The TvLPG is a component of the glycocalyx formed by
different carbohydrate-associated molecules that binds to
galectin-1 and -3 receptors in the host cells [74,75]. TvLPG
plays a role in the adherence and cytotoxicity to human cer-
vical cells and modulates inflammatory responses of epithe-
lial cells and macrophages [76]. It was already demonstrated
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human cervical and vaginal epithelial cells by the release of
chemokines as IL-8 andmacrophage inflammatory protein-3a
(MIP-3a). In opposition with TNF-a release it was shown that
this mechanism is independent of TLR4 expression [76]. To
date, trichomonad ligands for TLR4 have not been identified
and host receptors mediating these effects remain elusive.
More recently, it was demonstrated that galectin-1 and -3 are
expressed by the human cervical and vaginal epithelial cells
[75]. The study demonstrated that galectin-1 suppressed IL-8,
MIP-3a and RANTES chemokines that facilitate recruitment of
phagocytes, which can eliminate extracellular protozoa or
bridge innate to adaptive immunity [75]. In addition, the
investigation of inflammatory reaction triggered by T. vaginalis
in human prostate epithelial cell line was already conducted.
Co-incubation of prostate cell and parasites increased the
expression of the inflammatory mediators IL-1b, CCL2, and
CXCL8 [77]. Medium conditioned by incubation of prostate
cells with T. vaginalis trophozoites contained IL-1b and stim-
ulated the migration of human neutrophils and monocytes
[77].
Activation of chemokines and pro-inflammatory cytokines
in host immune cells during T. vaginalis infection with an
important role in innate and adaptive immunity have been
widely reported [78e82]. Neutrophils are the predominant
inflammatory cells found in the vaginal discharges of patients
infected with T. vaginalis. It was demonstrated that live tro-
phozoites can induce IL-8 production in neutrophils and that
this mechanism may be mediated through the NF-kB and
mitogen-activated protein kinases (MAPK) signaling pathways
[79]. This finding helps to explain howneutrophils accumulate
or mediate initial inflammatory response after acute T. vagi-
nalis infection. Neutrophil apoptosis induced by live T. vagi-
nalis is mediated by the activation of caspase-3 and reduced
expression of the neutrophil anti-apoptotic protein, induced
myeloid leukemia cell differentiation protein (Mcl-1) [82].
The recruitment of macrophages to the genitourinary tract
is also a critical component for host immune defense against
T. vaginalis. Trichomonads can stimulate macrophages and
DCs leading to production of immunosuppressive cytokines
such as IL-10 and TGFb [83]. Similarly to neutrophils, in mac-
rophages, caspase-3 has been related to the phosphorylation
of p38 MAPK signaling cascade which is located downstream
of mitochondria-dependent caspase activation [81]. Inflam-
matory responses induced by T. vaginalis in macrophages are
also associated with NF-kb activation dependent on Ikb-a
degradation. Further, the nuclear translocation of NF-kb was
inhibited by the parasite and in turn diminished the produc-
tion of IL-12 and TNF-a in response to stimulus [83]. Collec-
tively thesemolecularmechanisms indicate that the effects of
T. vaginalis on NF-kb regulation are critical for the production
of cytokine and macrophage survival, consequently suggest-
ing an existence of a T. vaginalis-induced immune evasion
from macrophage attack.
The macrophage migration inhibitory factor (MIF) is a pro-
inflammatory cytokine that modulates innate immunity in
inflammatory responses [84]. MIF promotes the production of
other proinflammatory mediators, such as TNFa, NO, and
prostaglandin E2 [84]. T. vaginalis macrophage migration
inhibitory factor (TvMIF) is 47% similar to humanmacrophagemigration inhibitory factor (HuMIF). The presence of anti-
TvMIF antibodies was detected in sera from patients infec-
ted with T. vaginalis, especially in men [85]. Considering that
chronic trichomoniasis has been associated with increased
risk of prostate cancer [15,86], these relevant data indicate
that chronic T. vaginalis infections may result in TvMIF-driven
inflammation and cell proliferation, thus triggering pathways
that contribute to the promotion and progression of aggres-
sive prostate cancer.The adaptive immune response to
trichomoniasis
The human infection by T. vaginalis results in specific serum
and local antibodies production, although there is little evi-
dence on its efficacy in the parasite in vivo clearance [87e89].
The specific IgG against T. vaginalis augmented LTB4 produc-
tion by neutrophils via the crucial complement common
pathway activation. Recently, a direct correlation between the
reduction of specific serum IgG anti-T. vaginalis response
detected by ELISA and the effective metronidazole therapy
was shown [90]. These findings may contribute to the search
for new diagnostic tools and techniques for trichomoniasis in
clinical samples.
In the last 40 years the presence of anti-T. vaginalis anti-
bodies (IgA, IgM, and IgG, and its subclasses) in serum and
cervicovaginal secretions has been demonstrated by radio-
immunoassay, ELISA, and immunofluorescence methods
[88e95]. IgE, when found in the genital tract, occurs in low
levels [89]. Nevertheless, in general is consensus that humoral
immunity is not long-lasting, and T. vaginalis cysteine pro-
teases secreted in the vaginal secretions and serum of
symptomatic women could degrade the levels of IgG, IgM, and
IgA [36]. This lack of effective and persistent humoral immu-
nity is also one of the causes of the difficulty in obtaining a
vaccine for trichomoniasis [96].
In a detailed study on TvLPG structure, Singh et al. (2009)
[97] revealed a dominant role for the CPI-GC core in the in-
duction of chemokine production, NF-kB and extracellular
signal-regulated kinase (ERK)1/2 activation in human cervi-
covaginal epithelial cells. Besides, considering the TvLPG role
in trichomoniasis virulence, recently, a study showed IgG
antibody response to conserved TvLPG antigen by testing
serum and vaginal samples from infected women [95]. In
addition, these women with normal pregnancies had higher
vaginal IgG anti-TvLPG levels than infected women with
adverse pregnancy outcomes. The conserved surface poly-
saccharide, poly-N-acetylglucosamine (PNAG), produced by
bacteria, fungi and protozoal parasites was also found in T.
vaginalis by using antigen-specific human IgG1, indicating an
evolutionary convergent acquisition of PNAG synthesis with
significance for microbial biology [98].Involvement of the purinergic signaling in
trichomoniasis immune response
Nucleotides can be found in the extracellular spaces and they
are mainly released by cells in physiological situations of
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Extracellular nucleotides and nucleosides can act as signaling
molecules through binding to specific receptors, named
purinoceptors, identified as P1 and P2 [102]. Enzymes located
on the cellular surface named ectonucleotidases are involved
in extracellular nucleotide hydrolysis. These enzymes include
the E-NTPDase family (ectonucleoside triphosphate diphos-
phohydrolase), the NPP family (ectonucleotide pyrophospha-
tase/phosphodiesterase), alkaline phosphatases, and ecto-50-
nucleotidase [103e105].
Purinoceptors and enzymes are expressed in immune cells
and the activation of these proteins alters the cellular immune
function [23]. ATP can act as a potent proinflammatory
molecule that promotes chemotaxis and degranulation of
mast cells, neutrophils and eosinophils, besides to activate
pain receptors and to increase the release of pro-inflammatory
cytokines [23,106e108]. In contrast, the final product of ATP
break down, adenosine, presents anti-inflammatory effect, in
general because of the predominant expression and activation
of A2A receptor inmonocytes/macrophages, DCs, neutrophils,
endothelial and epithelial cells, eosinophils, lymphocytes, NK
cells, and T-natural killers [109].
Among parasites, possible physiological functions are
attributed to enzymes involved in the nucleotide degradation,
related to protection from cytolytic effects of extracellular ATP
[110]. Our research group has investigated the purinergic
system in T. vaginalis biology mainly through the study of
ectonucleotidases. The biochemical characterization of the
complete enzyme cascade that breaks down ATP to adenosine
by NTPDases and ecto-50-nucleotidase with degradation of
adenosine to inosine by adenosine deaminase (ADA) has been
demonstrated [111e113]. Recently, we showed that five puta-
tive TvNTPDases (TvNTPDase1e5) were expressed by both fresh
clinical and long-term grown T. vaginalis isolates [114].
In addition, the regulation of trichomonads enzymes has
been studied. Our findings demonstrate that biochemical
NTPDase activity (ATP and ADP hydrolysis) and ecto-50-
nucleotidase are responsive to the serum-restrictive condition
and the gene expression of TvNTPDases was mostly
increased, mainly TvNTPDase2 and 4 [114,115]. The same en-
zymes activation effect could be observed when guanine nu-
cleotides hydrolysis was tested in parasites under serum
restriction, with higher adenosine uptake by parasites than
guanosine uptake [116]. These results indicate the preference
for adenosine by trichomonads, and are in agreement with
previous published data [117].
Besides serum restriction, the influence of iron on extra-
cellular nucleotide hydrolysis in T. vaginalis isolates from fe-
male and male patients was evaluated [118]. Iron from
hemoglobin and hemin significantly increased NTP-Dase ac-
tivity in fresh clinical T. vaginalis isolates from female patients
and conversely, reduced the enzyme activity in isolates from
male patients. Collectively, these results show the influence of
iron in trichomonads ectonucleotidases through ATP degra-
dation and adenosine production [118]. The ADA profile in
different T. vaginalis isolates treated with different iron sour-
ces or with limited iron availability was also evaluated. We
found a reduction in activity and an augment in ADA gene
expression after iron restriction by 2,2-bipyridyl and ferrozine
chelators [119]. These data support the hypothesis that ironcan modulate the activity of the enzymes involved in puri-
nergic signaling and it is implicated in establishing infection
and parasite survival.
Further the enzymes regulation, we were interested to
investigate whether the purinergic signaling would be
involved in the innate immune response during trichomoni-
asis. Indeed, the T. vaginalis trophozoites were able to induce
NO synthesis in neutrophils through iNOS pathway [66].
Importantly, adenosine and inosine promoted reduction on
NO secretion by trichomonads stimulated-neutrophils and
this immunosuppressive effect of the nucleosides occurred via
A2A receptor activation. Moreover, the T. vaginalis ecto-50-
nucleotidase activity appears to play a key role in adenosine
generation, indicating the efficiency of the purinergic cascade
in theprocess of immuneresponseevasionby theparasite [66].
Considering the increasing metronidazole resistance dis-
played by T. vaginalis isolates, it is imperative to search for
new treatment alternatives [21]. Several isolated compounds
and natural products have been tested in vitro against T. vag-
inalis with some success although no compound demon-
strated efficacy better than metronidazole to rouse the
pharmaceutical industry interest [120].We have characterized
the cytotoxic effect of the Amaryllidaceae alkaloids, candi-
mine and lycorine, against T. vaginalis, as well as the mecha-
nism of cellular death [121,122]. Taking into account that both
alkaloids were active against the trophozoites, we tested the
effect of compounds on ectonucleotidases. Indeed, NTPDase
and ecto-50-nucleotidase activities were strongly inhibited by
candimine and lycorine on 24 h-treated parasites, although
the effect was abolished when treated parasites were inocu-
lated in new culture medium without alkaloid [123]. Consid-
ering the proinflammatory role of ATP, which levels are
accumulated during the alkaloids treatment, the regulation of
extracellular nucleotide levels could be relevant in increasing
susceptibility of T. vaginalis to host immune response in the
presence of lycorine and candimine [123]. The adjuvant in-
flammatory effect produced by antitrichomonal agents could
be an interesting approach to the search to alternative treat-
ments for trichomoniasis, especially for the metronidazole
resistant cases.Final considerations
It is undoubted the important impact of trichomoniasis in
public health, including the serious consequences derived
from this STD and the costs in the healthcare system associ-
ated to T. vaginalis infection. Unfortunately, trichomoniasis is
not a reportable disease and increasing failures in diagnosis
and treatment are reported. Efforts have been made to un-
derstand how T. vaginalis succeeds parasitism and infection,
and the studies on the immunological aspects of the disease
have brought considerable advances that contribute to the
comprehension of host-parasite relation. The main immune
response during infection is the innate immunity, and the
adaptive response is also elicited although it is not persistent.
So far, we showed the involvement of the purinergic signaling
in T. vaginalis infection in the NO production by neutrophils
and the regulation of NTPDases and ADA by iron. Moreover, a
perspective on the adjuvant effect of anti-T. vaginalis
b i om e d i c a l j o u r n a l 3 9 ( 2 0 1 6 ) 2 3 4e2 4 3240compounds that modulate immune responses is a potential
alternative for trichomoniasis treatment. Studies should be
encouraged to foment the knowledge on immunological as-
pects of this STD with the great aim to achieve the reduction
of T. vaginalis burden.Conflicts of interest
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